Roozendaal, Ramon http://orcid.org/0000-0002-4084-4801
Solforosi, Laura
Stieh, Daniel J.
Serroyen, Jan
Straetemans, Roel
Dari, Anna
Boulton, Muriel
Wegmann, Frank
Rosendahl Huber, Sietske K.
van der Lubbe, Joan E. M.
Hendriks, Jenny
Le Gars, Mathieu
Dekking, Liesbeth
Czapska-Casey, Dominika N.
Guimera, Nuria http://orcid.org/0000-0002-4481-4386
Janssen, Sarah
Tete, Sarah
Chandrashekar, Abishek http://orcid.org/0000-0001-7821-5552
Mercado, Noe B. http://orcid.org/0000-0001-7769-7326
Yu, Jingyou
Koudstaal, Wouter
Perez-Ruixo, Juan J.
Sadoff, Jerry
Barouch, Dan H. http://orcid.org/0000-0001-5127-4659
Schuitemaker, Hanneke http://orcid.org/0000-0001-8563-2266
Zahn, Roland http://orcid.org/0000-0003-2822-6231
Article History
Received: 16 February 2021
Accepted: 16 September 2021
First Online: 7 October 2021
Competing interests
: R.R., L.S., D.J.S., J.S., R.S., A.D., M.B., F.W., S.K.R.H., J.E.M.v.d.L., J.H., M.L.G., L.D., D.N.C.C., N.G., S.J., S.T., J.J.P.R., J.Sa., H.S., and R.Z. were employees of Janssen Vaccines & Prevention B.V., a Janssen Pharmaceutical Company of Johnson & Johnson, at the time of the study, and may have ownership of shares in Johnson & Johnson. W.K. holds ownership of shares in Johnson & Johnson. F.W., D.H.B., H.S., and R.Z. are coinventors on provisional vaccine patents (62/969,008; 62/994,630). All other authors declare no competing interests.